JointMedica Polymotion Resurfacing Device Outcomes for Hip Patients

This study aims to evaluate the performance and safety of a hip implant device known as the JointMedica Polymotion Hip Resurfacing (PHR) device. It focuses on individuals who have already received this implant in Canada, New Zealand, and Australia. Up to 70 patients will be involved in this research to understand how well the implant is functioning over time. The study is important because it helps determine the durability and effectiveness of the implant, ensuring that it meets the needs of patients who rely on it for improved mobility and reduced pain. Participants will be asked to attend a follow-up visit as part of their standard care routine. During these visits, doctors will collect clinical data by conducting an x-ray of the hip and asking patients to fill out two questionnaires about their hip function and overall outcomes. The information collected, including the x-ray images, will be analyzed to see how well the implant is holding up, particularly the acetabular cup, which is a part of the hip joint. Researchers will look for any issues that might require additional surgery and monitor for any serious side effects related to the implant. This helps ensure that the device continues to be a safe and effective treatment option for patients.